Intuitive Surgical 在 2025 年第二季度的收益超出预期，每股收益为 $2.19，收入为 $2.44B，同比增长 21.4%。 Intuitive Surgical beat earnings estimates in Q2 2025 with $2.19 EPS and $2.44B in revenue, up 21.4% year-over-year.

直觉外科公司(ISRG)于7月22日报告第二季度收入强劲, 收入为2.19 EPS和24.4亿美元, 超过预期, Intuitive Surgical, Inc. (ISRG) reported strong second-quarter earnings on July 22, with $2.19 EPS and $2.44 billion in revenue, surpassing expectations and marking a 21.4% year-over-year revenue increase. 该公司以达芬奇外科和离子内光系统著称,其市场上限为1 581.3亿美元,P/E比率为61.52。 The company, known for its da Vinci Surgical and Ion endoluminal systems, has a market cap of $158.13 billion and a P/E ratio of 61.52. 机构投资者增加了其持有量,Embre金融集团、高额财富伙伴和Meridian投资顾问等公司购买股份,而一些内部人出售股票。 Institutional investors increased their holdings, with firms like Embree Financial Group, Highline Wealth Partners, and Meridian Investment Counsel buying shares, while some insiders sold stock. 分析员保持“机动购买”评级,平均价格目标为595.95美元,预测全年EPS为6.43美元。 Analysts maintain a "Moderate Buy" rating with a $595.95 average price target, forecasting full-year EPS of $6.43.